These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18597835)

  • 1. Ultrasound-estimated bladder weight predicts risk of surgery for benign prostatic hyperplasia in men using alpha-adrenoceptor blocker for LUTS.
    Akino H; Maekawa M; Nakai M; Shioyama R; Ishida H; Oyama N; Miwa Y; Yokoyama O
    Urology; 2008 Oct; 72(4):817-20. PubMed ID: 18597835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.
    Sironi D; Levorato CA; Deiana G; Borgonovo G; Belussi D; Ranieri A; Lembo A
    Arch Ital Urol Androl; 2002 Jun; 74(2):90-4. PubMed ID: 12161944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
    Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
    Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.
    Egilmez T; Pourbagher MA; Guvel S; Kilinc F; Turunc T; Ozkardes H
    Urol Int; 2006; 76(1):42-50. PubMed ID: 16401920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of Ultrasound Estimated Bladder Weight and Bladder Wall Thickness After Treatment of Bladder Outlet Obstruction With Dutasteride.
    Lee HN; Lee YS; Han DH; Lee KS
    Low Urin Tract Symptoms; 2017 May; 9(2):67-74. PubMed ID: 28394496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
    Krivoborodov GG; Efremov NS; Bolotov AD
    Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
    Liu Q; Zhu Y; Liu J; Qi J; Kang J
    Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Miyashita H; Kojima M; Miki T
    Ultrasound Med Biol; 2002 Aug; 28(8):985-90. PubMed ID: 12217433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of ultrasound-estimated bladder weight with ultrasound appearance of the prostate and postvoid residual urine in men with lower urinary tract symptoms.
    Ochiai A; Kojima M
    Urology; 1998 May; 51(5):722-9. PubMed ID: 9610585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
    Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Bladder and Prostate Sonomorphology Be Used for Detecting Bladder Outlet Obstruction in Patients With Symptomatic Benign Prostatic Hyperplasia?
    Ahmed AF; Bedewi M
    Urology; 2016 Dec; 98():126-131. PubMed ID: 27591808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound estimated bladder weight in men attending the uroflowmetry clinic.
    Bright E; Pearcy R; Abrams P
    Neurourol Urodyn; 2011 Apr; 30(4):583-6. PubMed ID: 21308749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the change of bladder wall weight pre and after surgery in patients with benign prostatic hyperplasia].
    Li HZ; Zhang XB; Li JC; Xiao H; Huang ZM
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):954-6. PubMed ID: 17961378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.
    Emberton M; Zinner N; Michel MC; Gittelman M; Chung MK; Madersbacher S
    BJU Int; 2007 Aug; 100(2):249-53. PubMed ID: 17617135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients with prostate up to 100 gr by endoscopic gyrus prostate resection versus open prostatectomy. Preliminary data.
    Giulianelli R; Brunori S; Gentile BC; Vincenti G; Nardoni S; Pisanti F; Shestani T; Mavilla L; Albanesi L; Attisani F; Mirabile G; Schettini M
    Arch Ital Urol Androl; 2011 Jun; 83(2):88-94. PubMed ID: 21826881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.
    Kawabe K; Yoshida M; Homma Y;
    BJU Int; 2006 Nov; 98(5):1019-24. PubMed ID: 16945121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary patients with LUTS/BPH requiring prostatectomy have long-term history of treatment with alpha1-blockers and large prostates compared with past cases.
    Takeuchi M; Masumori N; Tsukamoto T
    Urology; 2009 Sep; 74(3):606-9. PubMed ID: 19586655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.